Inventor · disambiguated record
Philip Stephen Jackson
Also filed as: JACKSON PHILIP · JACKSON PHILIP STEPHEN
16 granted patents·1 pending application·359 citations·filing 1997–2011
94Inventor score
Top patents by PatentIndex Score
17 records- 0194US6172077B1Spiro-azacyclic derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1998·Granted Jan 9, 2001·149 cites·15 claims
- 0291US8492427B2Isoindolones derivatives as MEK kinase inhibitors and methods of useGANCIA EMANUELA·Filed 2009·Granted Jul 23, 2013·36 cites·13 claims
- 0386US5952315AUse of NK-1 receptor antagonists for treating bipolar disordersMERCK SHARP & DOHME·Filed 1997·Granted Sep 14, 1999·34 cites·5 claims
- 0473US5929054AUse of NK-1 receptor antagonists for treating sexual dysfunctionsMERCK SHARP·Filed 1997·Granted Jul 27, 1999·41 cites·3 claims
- 0569US8841462B2Bicyclic heterocycles as MEK kinase inhibitorsHEALD ROBERT A·Filed 2009·Granted Sep 23, 2014·2 cites·19 claims
- 0667US7915300B2Cysteine protease inhibitorsMEDIVIR AB·Filed 2005·Granted Mar 29, 2011·1 cites·29 claims
- 0767US5977104AUse of NK-1 receptor antagonists for treating bipolar disordersMERCK SHARP & DOHME·Filed 1998·Granted Nov 2, 1999·29 cites·4 claims
- 0865US6114315AUse of NK-1 receptor antagonists for treating major depressive disorders with anxietyMERCK SHARP & DOHME·Filed 1998·Granted Sep 5, 2000·26 cites·4 claims
- 0956US6071927ASpiro-piperidine derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1997·Granted Jun 6, 2000·13 cites·24 claims
- 1048US5925627AUse of NK-1 receptor antagonists for treating movement disordersMERCK SHARP & DOHME·Filed 1997·Granted Jul 20, 1999·7 cites·11 claims
- 1143US6271230B1Use of NK-1 receptor antagonists for treating cognitive disordersMERCK SHARP & DOHME·Filed 1999·Granted Aug 7, 2001·6 cites·5 claims
- 1243US6100256AUse of NK-1 receptors antagonists for treating schizophrenic disordersMERCK SHARP & DOHME·Filed 1998·Granted Aug 8, 2000·7 cites·11 claims
- 1341US5919781AUse of NK-1 receptor antogonists for treating substance use disordersMERCK SHARP & DOHME·Filed 1997·Granted Jul 6, 1999·5 cites·6 claims
- 1440US2011112089A1Cysteine Protease InhibitorsMEDIVIR AB·Filed 2011·Application pending·0 cites
- 1538US6087348AUse of NK-1 receptor antagonists for treating stress disordersMERCK SHARP & DOHME·Filed 1999·Granted Jul 11, 2000·3 cites·15 claims
- 1633US6613765B1Use of NK-1 receptor antagonists for treating major depressive disordersMERCK SHARP & DOHME·Filed 1998·Granted Sep 2, 2003·0 cites·8 claims
- 1731US6096729AUse of NK-1 receptor antagonists for treating amnestic disordersMERCK SHARP & DOHME·Filed 1997·Granted Aug 1, 2000·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Philip Stephen Jackson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →